Does DEFIBROTIDE Cause Graft versus host disease? 85 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 85 reports of Graft versus host disease have been filed in association with DEFIBROTIDE (DEFITELIO). This represents 2.3% of all adverse event reports for DEFIBROTIDE.
85
Reports of Graft versus host disease with DEFIBROTIDE
2.3%
of all DEFIBROTIDE reports
60
Deaths
38
Hospitalizations
How Dangerous Is Graft versus host disease From DEFIBROTIDE?
Of the 85 reports, 60 (70.6%) resulted in death, 38 (44.7%) required hospitalization, and 8 (9.4%) were considered life-threatening.
Is Graft versus host disease Listed in the Official Label?
Yes, Graft versus host disease is listed as a known adverse reaction in the official FDA drug label for DEFIBROTIDE.
What Other Side Effects Does DEFIBROTIDE Cause?
Off label use (1,323)
Venoocclusive disease (576)
Death (463)
Multiple organ dysfunction syndrome (372)
Venoocclusive liver disease (355)
Intentional product use issue (201)
Hypotension (169)
Haemorrhage (156)
Sepsis (143)
Acute graft versus host disease (140)
What Other Drugs Cause Graft versus host disease?
CYCLOSPORINE (1,131)
TACROLIMUS (900)
MYCOPHENOLATE MOFETIL (890)
CYCLOPHOSPHAMIDE (653)
METHOTREXATE (615)
FLUDARABINE (541)
BUSULFAN (507)
RUXOLITINIB (469)
METHYLPREDNISOLONE (429)
PREDNISONE (405)
Which DEFIBROTIDE Alternatives Have Lower Graft versus host disease Risk?
DEFIBROTIDE vs DEFLAZACORT
DEFIBROTIDE vs DEGARELIX
DEFIBROTIDE vs DELAFLOXACIN MEGLUMINE
DEFIBROTIDE vs DELAMANID
DEFIBROTIDE vs DELANDISTROGENE MOXEPARVOVEC-ROKL